Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 3
593
Views
6
CrossRef citations to date
0
Altmetric
Synthetic Communications Reviews

Recent progress in the synthesis of diclofenac based NSAIDs analogs/derivatives

, , , &
Pages 325-350 | Received 30 Jan 2018, Published online: 10 Oct 2018

References

  • Birmingham, B.; Buvanendran, A. 40 - Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and COX-2 Inhibitors. in Practical Management of Pain, 5th ed.; Benzon, H. T.; Rathmell, J. P.; Wu, C. L.; Turk, D. C.; Argoff, C. E., and Hurley, R. W. Eds.; Mosby: Philadelphia, 2014; pp 553-568.
  • Vane, J. R. The Mode of Action of Aspirin and Similar Compounds. J. Allergy Clin. Immunol. 1976, 58, 691-712. DOI: 10.1016/0091-6749(76)90181-0.
  • Palomer, A.; Cabré, F.; Pascual, J.; Campos, J.; Trujillo, M. A.; Entrena, A.; Gallo, M. A.; García, L.; Mauleón, D.; Espinosa, A. Identification of Novel Cyclooxygenase-2 Selective Inhibitors Using Pharmacophore Models. J. Med. Chem. 2002, 45, 1402-1411. DOI: 10.1021/jm010458r.
  • Talley, J. J.; Brown, D. L.; Carter, J. S.; Graneto, M. J.; Koboldt, C. M.; Masferrer, J. L.; Perkins, W. E.; Rogers, R. S.; Shaffer, A. F.; Zhang, Y. Y.; et al. 4-[5-Methyl-3-Phenylisoxazol-4-yl]- Benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2. J. Med. Chem. 2000, 43, 775-777. DOI: 10.1021/jm990577v.
  • Tammara, V. K.; Narurkar, M. M.; Crider, A. M.; Khan, M. A. Morpholinoalkyl Ester Prodrugs of Diclofenac: Synthesis, in Vitro and in Vivo Evaluation. J. Pharm. Sci. 1994, 83, 644-648. DOI: 10.1002/jps.2600830510.
  • Michaelidou, A. S.; Hadjipavlou-Litina, D. Nonsteroidal anti-Inflammatory Drugs (NSAIDs): a Comparative QSAR Study. Chem. Rev. 2005, 105, 3235-3271. DOI: 10.1021/cr040708m.
  • Scheiman, J. M. Use of NSAIDs in Treating Patients with. Arthritis Res. Ther. 2013, 15, S2-S5. DOI: 10.1186/ar4174.
  • Buer, J. K. Origins and Impact of the Term ‘NSAID’. Inflammopharmacol. 2014, 22, 263-267. DOI: 10.1007/s10787-014-0211-2.
  • Sayen, S.; Carlier, A.; Tarpin, M.; Guillon, E. A Novel Copper(II) Mononuclear Complex with the Non-Steroidal anti-Inflammatory Drug Diclofenac: Structural Characterization and Biological Activity. J. Inorg. Biochem. 2013, 120, 39-43. DOI: 10.1016/j.jinorgbio.2012.12.002.
  • Altman, R.; Bosch, B.; Brune, K.; Patrignani, P.; Young, C. Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology. Drugs 2015, 75, 859-877. DOI: 10.1007/s40265-015-0392-z.
  • Sallmann, A. R. The History of Diclofenac. Semin. Arthritis. Rheum. 1985, 15, 57-60. DOI: 10.1016/S0049-0172(85)80011-1.
  • Meinicke, J.; Danneskiold, S.; B. Diclofenac Sodium (Voltaren) and Ibuprofen in Rheumatoid Arthritis. A Randomized Double-Blind Study. Scand. J. Rheumatol. Suppl. 1980, 9, 1-8. DOI: 10.3109/03009748009101380.
  • Ghosh, S.; Barik, B. B. Preparation and Evaluation of Aceclofenac Sustained Release Formulation and Comparison of Formulated and Marketed Product. Int. J. Med. Med. Sci. 2009, 1, 375-382.
  • Vásquez, B. D.; Salazar, M. U.; Ortiz, M.; Castañeda, H. G.; Trocóniz, I. Pharmacokinetic-Pharmacodynamic Modelling of the Analgesic Effects of Lumiracoxib, a Selective Inhibitor of Cyclooxygenase-2, in Rats. Br. J. Pharmacol. 2010, 159, 176-187. DOI: 10.1111/j.1476-5381.2009.00508.x.
  • Kalbag, J.; Yeh, C. M.; Milosavljev, S.; Lasseter, K.; Oberstein, S.; Rordorf, C. No Influence of Moderate Hepatic Impairment on the Pharmacokinetics of Lumiracoxib, an Oral COX-2 Selective Inhibitor. Pharmacol. Res. 2004, 50, 181-186. DOI: 10.1016/j.phrs.2004.03.002.
  • Moser, P.; Sallmann, A.; Wiesenberg, I. Synthesis and Quantitative Structure-Activity Relationships of Diclofenac Analogs. J. Med. Chem. 1990, 33, 2358-2368. DOI: 10.1021/jm00171a008.
  • Kato, Y.; Shinuchi, T. (Teikoko Kakagu Sangyo) Jap. Granted Pat. Appl. 1980, 80, 374.
  • Leroy, D.; Richard, J.; Godbillon, J. Synthesis of Deuterium-Labelled Diclofenac Sodium. J. Label. Compd. Radiopharm. 1993, 33, 1019-1027. DOI: 10.1002/jlcr.2580331105.
  • Keying, W.; Lei, T.; Hongye, L.; Jian, L.; Liqin, C. Synthesis of Deuterium Labelled Diclofenac with Improved Isotopic Enrichment. J. Label. Compd. Radiopharm. 2009, 52, 535-537. DOI: 10.1002/jlcr.1669.
  • Petroni, D.; Menichetti, L.; Sorace, O.; Poli, M.; Vanasia, M.; Salvadori, P. A. [11C]Diclofenac Sodium: synthesis and PET Assessment of Transdermal Penetration. Nucl. Med. Biol. 2011, 38, 181-189. DOI: 10.1016/j.nucmedbio.2010.08.005.
  • Ian, W. Synthesis of Deuterium Labelled 4′-Hydroxydiclofenac. J. Labelled Cpd. Radiopharm. 1999, 42, 1075-1083. DOI: 10.1002/(SICI)1099-1344(199911)42:11 < 1075::AID-JLCR263 > 3.0.CO;2-A.
  • Kenny, J. R.; Maggs, J. L.; Meng, X.; Sinnott, D.; Clarke, S. E.; Park, B. K.; Stachulski, A. V. Syntheses and Characterization of the Acyl Glucuronide and Hydroxy Metabolites of Diclofenac. J. Med. Chem. 2004, 47, 2816-2825. DOI: 10.1021/jm030891w.
  • Kim, S.-H.; Kwon, J.-H.; Yoon, S.-H. An Improved Synthesis of 4'-Hydroxydiclofenac. Bull. Korean Chem. Soc. 2010, 31, 3007-3009. DOI: 10.5012/bkcs.2010.31.10.3007.
  • Fleming, S. A.; Ridges, M. D.; Jensen, A. W. Synthesis of Non-Steroidal Antiinflammatory Drug Analogues for Selective Studies on the COX-II Enzyme. J. Label. Compd. Radiopharm. 1996, 38, 13-18. DOI: 10.1002/(SICI)1099-1344(199601)38:1<13::AID-JLCR807>3.0.CO;2-D.
  • Oza, V. B.; Smith, C.; Raman, P.; Koepf, E. K.; Lashuel, H. A.; Petrassi, H. M.; Chiang, K. P.; Powers, E. T.; Sachettinni, J.; Kelly, J. W. Synthesis, Structure, and Activity of Diclofenac Analogues as Transthyretin Amyloid Fibril Formation Inhibitors. J. Med. Chem. 2002, 45, 321-332. DOI: 10.1021/jm010257n.
  • Amir, M.; Shikha, K. Synthesis and anti-Inflammatory, Analgesic, Ulcerogenic and Lipid Peroxidation Activities of Some New 2-[(2,6-Dichloroanilino) Phenyl]Acetic Acid Derivatives. Eur. J. Med. Chem. 2004, 39, 535-545. DOI: 10.1016/j.ejmech.2004.02.008.
  • Winter, C. A.; Risley, E. A.; Nus, G. N. Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiiflammatory Drugs. Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547. DOI: 10.3181/00379727-111-27849.
  • Koster, R.; Anderson, M.; Beer, E. J. D. Acetic Acid for Analgesic Screening. Fed. Proc. 1959, 18, 412.
  • Cioli, V.; Putzolu, S.; Rossi, V.; Barcellona, P. S.; Corradino, C. The Role of Direct Tissue Contact in the Production of Gastrointestinal Ulcers by anti-Inflammatory Drugs in Rats. Toxicol. Appl. Pharmacol. 1979, 50, 283-289. DOI: 10.1016/0041-008X(79)90153-4.
  • Sriram, D.; Yogeeswari, P.; Devakaram, R. V. Synthesis, in Vitro and in Vivo Antimycobacterial Activities of Diclofenac Acid Hydrazones and Amides. Bioorg. Med. Chem. 2006, 14, 3113-3118. DOI: 10.1016/j.bmc.2005.12.042.
  • Barbarić, M.; Kralj, M.; Marjanović, M.; Husnjak, I.; Pavelić, K.; Filipović-Grčić, J.; Zorc, D.; Zorc, B. Synthesis and in Vitro Antitumor Effect of Diclofenac and Fenoprofen Thiolated and Nonthiolated Polyaspartamide-Drug Conjugates. Eur. J. Med. Chem. 2007, 42, 20-29. DOI: 10.1016/j.ejmech.2006.08.009.
  • Bhandari, S. V.; Bothara, K. G.; Raut, M. K.; Patil, A. A.; Sarkate, A. P.; Mokale, V. J. Design, Synthesis and Evaluation of Antiinflammatory, Analgesic and Ulcerogenicity Studies of Novel S-Substituted Phenacyl-1,3,4-Oxadiazole-2-Thiol and Schiff Bases of Diclofenac Acid as Nonulcerogenic Derivatives. Bioorg. Med. Chem. 2008, 16, 1822-1831. DOI: 10.1016/j.bmc.2007.11.014.
  • Manon, B.; Sharma, P. D. Design, Synthesis and Evaluation of Diclofenac-Antioxidant Mutual Prodrugs as Safer NSAIDs. Indian J. Chem. B 2009, 48B, 1279-1287.
  • Zhang, J.; Wang, J.; Wu, H.; He, Y.; Zhu, G.; Cui, X.; Tang, L. Design, Synthesis and Insulin-Sensitizing Activity of Indomethacin and Diclofenac Derivatives. Bioorg. Med. Chem. Lett. 2009, 19, 3324-3327. DOI: 10.1016/j.bmcl.2009.04.050.
  • de Carvalho, P. S.; Maróstica, M.; Gambero, A.; Pedrazzoli, J. Synthesis and Pharmacological Characterization of a Novel Nitric Oxide-Releasing Diclofenac Derivative Containing a Benzofuroxan Moiety. Eur. J. Med. Chem. 2010, 45, 2489-2493. DOI: 10.1016/j.ejmech.2010.02.034.
  • Neves, C. M. B.; Simoes, M. M. Q.; Domingues, M. R. M.; Santos, I. C. M. S.; Neves, M. G. P. M. S.; Paz, F. A. A.; Silva, A. M. S.; Cavaleiro, J. A. S. Oxidation of Diclofenac Catalyzed by Manganese Porphyrins: synthesis of Novel Diclofenac Derivatives. RSC Adv. 2012, 2, 7427-7438. DOI: 10.1039/c2ra20801f.
  • El-Henawy, A. A. Synthesis, Characterization, AMDET and DOCKING Studies of Novel Diclofenac Derivatives Containing Phenylalanine Moiety Acting as Selective Inhibitors against Cyclooxygenase (COX-2). Chem. Mater. Res. 2013, 3, 75-89.
  • Jilani, J.; Idkaidek, N.; Alzoubi, K. Synthesis, in Vitro and in Vivo Evaluation of the N-Ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug. Pharmaceuticals (Basel) 2014, 7, 453 DOI: 10.3390/ph7040453.
  • Palkar, M. B.; Singhai, A. S.; Ronad, P. M.; Vishwanathswamy, A. H. M.; Boreddy, T. S.; Veerapur, V. P.; Shaikh, M. S.; Rane, R. A.; Karpoormath, R. Synthesis, Pharmacological Screening and in Silico Studies of New Class of Diclofenac Analogues as a Promising anti-Inflammatory Agents. Bioorg. Med. Chem. 2014, 22, 2855-2866. DOI: 10.1016/j.bmc.2014.03.043.
  • Amir, M.; Akhter, M. W.; Somakala, K. Synthesis, In Vitro and In Vivo Evaluation of the N-Ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug. Indian J. Chem. 2016. 55B, 989-998.
  • Elsaman, T.; Aldeeb, O. A. A.; Aboul-Fadl, T.; Al-Dhfyan, A. Synthesis and Antiproliferative Activity of Some Novel Amides of Flufenamic Acid and Diclofenac. Der. Pharma. Chemica. 2016, 8, 434-443.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.